• Soligenix plans to apply to CEPI for funding to develop a Bundibugyo Ebola vaccine, following CEPI’s call for proposals due June 12, 2026.
• The bid is being prepared with University of Hawaiʻi at Mānoa researcher Axel Lehrer, aiming to advance a thermostable protein-based subunit vaccine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Soligenix Inc. published the original content used to generate this news brief on June 08, 2026, and is solely responsible for the information contained therein.